R & d-alcohol dependency-a RES/expl d

Ended Definitive Contract Awarded Last action

Contract number
HHSN267200800020C
Awardee
Awarding agency
Obligated
$150,191

Award facts

Opportunity
Contract value 100% obligated
$150,191.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
Total Small Business
Competition
Full and Open Competition after exclusion of sources · 3 offers Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Emigration Canyon, UT 84108, USA
Research
SBIR Program Phase I Action

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Supplemental Agreement for work within scope 3 · Echelon biosciences, INC. Sbir phase i 10-month no-cost extension $0
Supplemental Agreement for work within scope 2 · (niaaa-09-17) echelon biosciences, INC. Sbir phase i 6-month no-cost extension (epps) $0
Supplemental Agreement for work within scope 1 · Sbir phase i - biomarkers for alcohol and ALD (5-month no-cost-extension) $0
Original award $150,191

About this award

This federal contract award was made by the National Institute of Diabetes and Digestive and Kidney Diseases, a civilian agency, to Echelon Biosciences Inc., a for-profit organization that manufactures goods. The $150,191.00 contract is for research and development related to alcohol dependency, under the SBIR (Small Business Innovation Research) Program Phase I. It is structured as a definitive, firm fixed-price contract. The contract was set aside for a total small business.

Echelon Biosciences Inc. is a subsidiary of Frontier Scientific, Inc., which also does business as Porphyrin Products. Frontier Scientific is a for-profit organization that specializes in scientific research and development, particularly in chemical synthesis and biological products. The company has experience providing custom synthesis and research support services to various federal agencies, including the Department of Agriculture and the Department of the Army.

Quick answers

Who was awarded contract HHSN267200800020C?

HHSN267200800020C was awarded to Echelon Biosciences Inc. by National Institute of Diabetes and Digestive and Kidney Diseases (National Institutes of Health) on September 22, 2008.

How much is contract HHSN267200800020C worth?

The government has obligated $150,191 on HHSN267200800020C.

Was contract HHSN267200800020C competed?

The extent of competition for HHSN267200800020C was full and open competition after exclusion of sources. The government received 3 offers. It was set aside: Total Small Business.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award